Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Pediatric Rheumatology Online Journal|January 3, 2024
The 4<sup>th</sup> NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design studyFabrizio de Benedetti, Alexei A Grom, Hermine Brunner
Paediatric Drugs|October 3, 2023
Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung DiseaseChristopher Towe, Alexei A Grom, Grant S Schulert
Nature Reviews. Rheumatology|March 25, 2016
Macrophage activation syndrome in the era of biologic therapyAlexei A Grom, AnnaCarin Horne, Fabrizio De Benedetti
Pediatric Rheumatology Online Journal|January 5, 2024
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIAGrant Schulert, Sebastiaan J Vastert, Alexei A Grom
Arthritis and Rheumatism|June 29, 2012
The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsivenessKeith A Sikora, Ndate Fall, Sherry Thornton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2021
Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic ArthritisEmely L Verweyen, Alex Pickering, Alexei A Grom, et al.
Nature Reviews. Rheumatology|October 6, 2021
Targeting interferon-γ in hyperinflammation: opportunities and challengesFabrizio De Benedetti, Giusi Prencipe, Claudia Bracaglia, et al.
Biopreservation and Biobanking|July 12, 2011
Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing DelaysMichael G Barnes, Alexei A Grom, Thomas A Griffin, et al.
The Journal of Pediatrics|March 18, 2003
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndromeAlexei A Grom, Joyce Villanueva, Susan Lee, et al.
Arthritis Care & Research|November 3, 2024
Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response PredictionEsraa Eloseily, Alex Pickering, Sanjeev Dhakal, et al.
Pageof 9